Is tocilizumab a potential therapeutic option for refractory unicentric Castleman disease?

Muhammad Bilal Abid, Rachel Peck, Muhammad Abbas Abid, Wesam Al-Sakkaf, Yuening Zhang, Giles S Dunnill, Konrad Staines, Iara M Sequeiros, Lisa Lowry

Research output: Contribution to journalArticle (Academic Journal)peer-review

7 Citations (Scopus)
321 Downloads (Pure)

Fingerprint Dive into the research topics of 'Is tocilizumab a potential therapeutic option for refractory unicentric Castleman disease?'. Together they form a unique fingerprint.

Medicine & Life Sciences